Перейти к анализу отчёта
← Назад к ленте
SOLV FY2026 Q1 IMPROVING

Отчётный звонок Solventum Corporation

May 05, 2026 · 16:30 ET Amy WakehamBrian HansonWade McMillan
Вывод Buzzberg

Q1 results beat plan; EPS raised to high end of guidance

Solventum's Q1 results exceeded expectations, driven by strong commercial execution and new product launches. Management reiterated full-year guidance while providing color on a significant ERP-driven Q2 sales pull-forward and continued portfolio optimization. Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.

Вывод Buzzberg Q1 results beat plan; EPS raised to high end of guidance Solventum's Q1 results exceeded expectations, driven by strong commercial execution and new product launches. Management reiterated full-year guidance while providing color on a significant ERP-driven Q2 sales pull-forward and continued portfolio optimization. Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%. Читать полный анализСвернуть анализ

Solventum's Q1 results exceeded expectations, driven by strong commercial execution and new product launches. Management reiterated full-year guidance while providing color on a significant ERP-driven Q2 sales pull-forward and continued portfolio optimization. Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.

  • Full-year EPS guidance raised to high end of $6.40-$6.60 range while maintaining top-line and margin guidance.
  • Expecting over $100M sales pull-forward into Q2 from Q3 ERP cutover; will be reversed in Q3.
  • Portfolio optimization continues with strategic tuck-in acquisitions (Acera) and ongoing P&F divestiture.
Revenue $2.007B +0% QoQ
EPS $1.48 -6% QoQ
Gross margin 54.66% reported
Op margin 4.04% reported

Что изменилось в этом квартале

01
Guidance

Q1 results beat plan; EPS raised to high end of guidance

Guidance tone

02
Macro

Tariff headwinds expected at $100-120 million annually

Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.

03
Buybacks

Share buybacks to accelerate given undervalued shares

Full-year EPS guidance raised to high end of $6.40-$6.60 range while maintaining top-line and margin guidance.

04
Supply Chain

US ERP cutover to cause Q2 sales timing benefit over $100M

Expecting over $100M sales pull-forward into Q2 from Q3 ERP cutover; will be reversed in Q3.

AI, капзатраты и спрос

AI

Платформа и монетизация

Management sees AI as a helpful tool for autonomous coding, differentiating on data, rules, and rigor. They report growing traction in outpatient and inpatient settings, with compelling economics for customers, and expect up to 50% of customers to adopt autonomous coding during the LRP period.

Спрос

Заказы и конверсия

Management expresses confidence about hitting LRP targets, with a robust new product pipeline, strong commercial execution, and continued margin expansion despite headwinds.

Тон · Confident

Management repeatedly emphasized momentum, execution, and faster-than-expected progress toward long-range targets, while maintaining full-year guidance.

Альфа цепочки поставок

A1

Solventum is pulling forward over $100M of sales from Q3 into Q2 as a mitigation strategy ahead of their last major ERP cutover in the US/Canada.

“we are estimating over 100 million additional sales in Q2 as we're working with our customers and distributors to advance orders before we begin our Q3 cutover of ERPs in the US and Canada.”
Wade McMillan

Прогноз компании

ImprovingGuidance tone · was IN LINE last Q
Прогноз компании
ПоказательПериодДиапазонСерединаСтатус
EPSFY2026$6.40–$6.60$6.50MAINTAINED